Revelation Biosciences Inc

Research Revelation Biosciences Inc (REVB) on Bullrun: market cap USD 4.06M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerREVB
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 4.06M
• Financial periodFY2025
• Net income-USD 8.91M

Valuation Snapshot

latest market cap is USD 4.06M.

About Revelation Biosciences Inc

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response.

Frequently asked questions

What is Revelation Biosciences Inc's market cap?

Revelation Biosciences Inc's market capitalization is USD 4.06M.

What does Revelation Biosciences Inc do?

Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.